Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
IGM Biosciences Inc
IGMSCurrent price
12.1 USD
-0.1 USD (-0.82%)
Last closed
12.33 USD
Company
igmbio.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
633 913 472 USD
Yield for 12 month
+21.73 %
1Y
3Y
5Y
10Y
15Y
IGMS
IGM Biosciences, Inc., a clinical-stage biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer and autoimmune and inflammatory diseases. It develops Aplitabart, a Death Receptor 5 Agonist IgM antibody for the treatment of colorectal cancer; imvotamab, a CD20 x CD3 bispecific IgM antibody to treat myositis, as well as for the treatment of systemic lupus erythematosus and rheumatoid arthritis that is Phase Ib clinical trial; and IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of autoimmune diseases. IGM Biosciences, Inc. has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. Address: 325 East Middlefield Road, Mountain View, CA, United States, 94043
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
22.56 USDP/E ratio
–Dividend Yield
–Current Year
+2 130 000 USD
Last Year
+1 069 000 USD
Current Quarter
+497 000 USD
Last Quarter
+651 000 USD
Current Year
-6 146 999 USD
Last Year
+1 069 000 USD
Current Quarter
-1 679 000 USD
Last Quarter
-1 530 000 USD
Key Figures IGMS
1 year
3 years
5 years
10 years
EBITDA
-243 328 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.57 %
PEG Ratio
–
Return On Equity TTM
-118.26 %
Wall Street Target Price
22.56 USD
Revenue TTM
2 105 000 USD
Book Value
2.74 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-4.8 %
Dividend Yield
–
Gross Profit TTM
1 069 000 USD
Earnings per share
-4.21 USD
Diluted Eps TTM
-4.21 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics IGMS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History IGMS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation IGMS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
113.293
Price Sales TTM
252.81
Enterprise Value EBITDA
-0.9456
Price Book MRQ
2.6496
Financials IGMS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators IGMS
For 52 weeks
3.81 USD
17.7 USD
50 Day MA
8.35 USD
Shares Short Prior Month
5 175 209
200 Day MA
8.8 USD
Short Ratio
16.64
Shares Short
5 216 905
Short Percent
35.32 %
BeatStart